OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
Djordje S. Popovic, Νικόλαος Παπάνας, Anca Pantea Stoian, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 12, pp. 3037-3054
Open Access | Times Cited: 15

Showing 15 citing articles:

Metformin: Sex/Gender Differences in Its Uses and Effects—Narrative Review
Ιoannis Ilias, Manfredi Rizzo, Lina Zabulienė
Medicina (2022) Vol. 58, Iss. 3, pp. 430-430
Open Access | Times Cited: 23

Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13

The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact
Nitin Kapoor, Sanjay Kalra, Wael Al Mahmeed, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 10, pp. 1723-1736
Open Access | Times Cited: 18

Insight on Infections in Diabetic Setting
Bianca Pari, Matteo Gallucci, Alberto Ghigo, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 971-971
Open Access | Times Cited: 9

Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel
Djordje S. Popovic, Νικόλαος Παπάνας, Theocharis Koufakis, et al.
Experimental and Clinical Endocrinology & Diabetes (2023) Vol. 131, Iss. 05, pp. 260-267
Closed Access | Times Cited: 8

COVID-19 and diabetes—Two giants colliding: From pathophysiology to management
Maria Chiara Pelle, Isabella Zaffina, Michele Provenzano, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13

Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11

Diabetic Foot Syndrome in the COVID-19 era: How to Move from Classical to new Approaches
Roberto Anichini, Claudia Cosentino, Νικόλαος Παπάνας
The International Journal of Lower Extremity Wounds (2022) Vol. 21, Iss. 2, pp. 107-110
Open Access | Times Cited: 10

Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us
Anca Pantea Stoian, Péter Kempler, Thomas M. Stulnig, et al.
Metabolic Syndrome and Related Disorders (2021) Vol. 20, Iss. 3, pp. 137-140
Closed Access | Times Cited: 5

Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study
Alexandra Abegão Matias, Inês Manique, Teresa Sabino, et al.
Diabetes Therapy (2022) Vol. 14, Iss. 2, pp. 335-346
Open Access | Times Cited: 3

Current management of diabetes patients with COVID-19
Arup Kumar Misra, Gaurav Rangari, C Madhavrao, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 199-207
Closed Access | Times Cited: 1

Treatment of diabetes and heart failure: Facts and hopes
Manfredi Rizzo, Domenico Cianflone, Francesco Maranta
International Journal of Cardiology (2022) Vol. 359, pp. 118-119
Closed Access | Times Cited: 2

Current management of diabetes patients with COVID-19
Arup Kumar Misra, Gaurav Rangari, C Madhavrao, et al.
Expert Review of Endocrinology & Metabolism (2023), pp. 1-9
Closed Access

The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases
Manfredi Rizzo
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2483-2485
Closed Access

Page 1

Scroll to top